Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results?
暂无分享,去创建一个
Jennifer J Linderman | Christopher J Brinkerhoff | J. Linderman | Christopher J. Brinkerhoff | J. Traynor | John R Traynor
[1] J. Traynor,et al. The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. , 2003, Life sciences.
[2] R. Lefkowitz,et al. Regulation of G protein-coupled receptor signaling by scaffold proteins. , 2002, Circulation research.
[3] R. Lefkowitz,et al. Correlation of beta-adrenergic receptor-stimulated [3H]GDP release and adenylate cyclase activation. Differences between frog and turkey erythrocyte membranes. , 1981, The Journal of biological chemistry.
[4] R. Pollenz,et al. Determination of aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear t , 1997, Molecular pharmacology.
[5] J. Linderman,et al. Threshold and graded response behavior in human neutrophils: effect of varying G-protein or ligand concentrations. , 1998, Biochemistry.
[6] U. Bhalla,et al. Emergent properties of networks of biological signaling pathways. , 1999, Science.
[7] K. Standifer,et al. Involvement of G Protein-Coupled Receptor Kinase (GRK) 3 and GRK2 in Down-Regulation of the α2B-Adrenoceptor , 2006, Journal of Pharmacology and Experimental Therapeutics.
[8] J. Traynor,et al. The [35S]GTPγS binding assay: approaches and applications in pharmacology , 2003 .
[9] M. Saxton. Fluorescence corralation spectroscopy. , 2005, Biophysical journal.
[10] R. Neubig,et al. Endogenous RGS Protein Action Modulates μ-Opioid Signaling through Gαo , 2003, The Journal of Biological Chemistry.
[11] Patricia H Reggio,et al. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. , 2005, Life sciences.
[12] R. Neubig,et al. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. , 1993, Molecular pharmacology.
[13] R. Neubig,et al. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. , 2003, The Journal of biological chemistry.
[14] J. Traynor,et al. Endogenous Regulator of G Protein Signaling Proteins Reduce μ-Opioid Receptor Desensitization and Down-Regulation and Adenylyl Cyclase Tolerance in C6 Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.
[15] A. Yew,et al. Computational model of the cAMP-mediated sensory response and calcium-dependent adaptation in vertebrate olfactory receptor neurons. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Neubig,et al. Fluorescence analysis of receptor-G protein interactions in cell membranes. , 2002, Biochemistry.
[17] J. Traynor,et al. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists. , 2002, The Journal of pharmacology and experimental therapeutics.
[18] D. Lauffenburger,et al. Receptors: Models for Binding, Trafficking, and Signaling , 1993 .
[19] A. Herz,et al. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. , 1988, Molecular pharmacology.
[20] Peter J Woolf,et al. A Spatial Focusing Model for G Protein Signals , 2003, The Journal of Biological Chemistry.
[21] D. Lewis,et al. The CB1 Cannabinoid Receptor Can Sequester G-Proteins, Making Them Unavailable to Couple to Other Receptors , 1999, The Journal of Neuroscience.
[22] H. Kitano,et al. A quantitative characterization of the yeast heterotrimeric G protein cycle , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Linderman,et al. Calculation of diffusion-limited kinetics for the reactions in collision coupling and receptor cross-linking. , 1997, Biophysical journal.
[24] Terrence P. Kenakin,et al. A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .
[25] E M Ross,et al. Rapid GTP binding and hydrolysis by G(q) promoted by receptor and GTPase-activating proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] P. Prather,et al. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. , 2001, Molecular pharmacology.
[27] Peter J Woolf,et al. An algebra of dimerization and its implications for G-protein coupled receptor signaling. , 2004, Journal of theoretical biology.
[28] Shankar Subramaniam,et al. Computational modeling reveals how interplay between components of a GTPase-cycle module regulates signal transduction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Brown,et al. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells. , 1986, Molecular pharmacology.
[30] A. Levitzki,et al. Mode of coupling between the beta-adrenergic receptor and adenylate cyclase in turkey erythrocytes. , 1978, Biochemistry.
[31] M. Millan,et al. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. , 1999, Molecular pharmacology.
[32] D. Selley,et al. Cannabinoid Receptor Agonist Efficacy for Stimulating [35S]GTPγS Binding to Rat Cerebellar Membranes Correlates with Agonist-induced Decreases in GDP Affinity* , 1998, The Journal of Biological Chemistry.
[33] Akihiro Kusumi,et al. Detection of non-Brownian diffusion in the cell membrane in single molecule tracking. , 2005, Biophysical journal.
[34] M. Ui,et al. [3H]GDP release from rat and hamster adipocyte membranes independently linked to receptors involved in activation or inhibition of adenylate cyclase. Differential susceptibility to two bacterial toxins. , 1984, The Journal of biological chemistry.
[35] D. Stickle,et al. Estimation of the kinetic constants for binding of epinephrine to beta-adrenergic receptors of the S49 cell. , 1991, Biochemical pharmacology.
[36] T. Costa,et al. Enzymatic degradation of GTP and its "stable" analogues produce apparent isomerization of opioid receptors. , 1989, Journal of receptor research.
[37] Z. Vogel,et al. Opioid and Cannabinoid Receptors Share a Common Pool of GTP-Binding Proteins in Cotransfected Cells, But Not in Cells Which Endogenously Coexpress the Receptors , 2000, Cellular and Molecular Neurobiology.
[38] J. Lameh,et al. Activity of opioid ligands in cells expressing cloned mu opioid receptors , 2003, BMC pharmacology.
[39] B. Carter,et al. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[40] P. Hawkins,et al. Turkey erythrocyte membranes as a model for regulation of phospholipase C by guanine nucleotides. , 1987, The Journal of biological chemistry.
[41] J. Linderman,et al. Compartmentalization of Receptors and Enzymes Affects Activation for a Collision Coupling Mechanism , 1998 .
[42] J. Woods,et al. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. , 2001, The Journal of pharmacology and experimental therapeutics.
[43] Nicolas Destainville,et al. Confined diffusion without fences of a g-protein-coupled receptor as revealed by single particle tracking. , 2003, Biophysical journal.
[44] J. Woods,et al. Activation of G protein by opioid receptors: role of receptor number and G-protein concentration. , 2000, European journal of pharmacology.
[45] R. Fantozzi,et al. Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlornaltrexamine. , 1981, Molecular Pharmacology.
[46] J. Woods,et al. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH‐SY5Y cells , 2002, British journal of pharmacology.
[47] Rapid kinetics of alpha 2-adrenergic inhibition of adenylate cyclase. Evidence for a distal rate-limiting step. , 1989, Biochemistry.
[48] Gerda E Breitwieser,et al. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. , 2004, Circulation research.
[49] N. Gautam,et al. A Fluorescence Resonance Energy Transfer-based Sensor Indicates that Receptor Access to a G Protein Is Unrestricted in a Living Mammalian Cell*[boxs] , 2004, Journal of Biological Chemistry.
[50] Y. Sarne,et al. Divers pathways mediate δ-opioid receptor down regulation within the same cell , 2001 .
[51] C. Mandyam,et al. μ-Opioid-Induced Desensitization of Opioid Receptor-Like 1 and μ-Opioid Receptors: Differential Intracellular Signaling Determines Receptor Sensitivity , 2003, Journal of Pharmacology and Experimental Therapeutics.
[52] R. Rigler,et al. Fluorescence correlation spectroscopy , 2001 .